TCL Archive NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say. April 16, 2004
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive NCI Programs: Institute Renews 10 Center Grants, Provides Complete Grant List. January 28, 2005
TCL Archive In Brief: Cancer Program Bill Renews Congressional Commitment To Principles, Rep. Carter Says May 5, 1978
TCL Archive Five Proposals Submitted In Recompetition Of FCRF Operations/Support Contract; Now Under Review January 2, 1987
TCL Archive Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision December 2, 2011
